{
    "2020-03-24": [
        [
            {
                "time": "2019-01-01",
                "original_text": "2019年研发提速，中国抗体-B(03681)投资价值持续凸显",
                "features": {
                    "keywords": [
                        "研发提速",
                        "中国抗体",
                        "投资价值"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-02-01",
                "original_text": "2300万元助云南白药集团生产抗“疫”药品",
                "features": {
                    "keywords": [
                        "2300万元",
                        "云南白药",
                        "抗疫药品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}